Psychiatric Digital Biomarkers Market Size, Share, Trends, Growth and Forecast 2034
Psychiatric Digital Biomarkers Market By Type (Wearables, Mobile-based Applications, Sensors, and Others), By Clinical Practice (Diagnostic, Monitoring, Predictive and Prognostic, and Others), By End-Use (Healthcare Companies, Healthcare Providers, Payers, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Healthcare Report Format : PDF
Pages: 211 Report Code: ZMR-9582
Published Date: Jun-2025 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 6.40 Billion | USD 26.60 Billion | 19.50% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Psychiatric Digital Biomarkers Market, (2025 - 2034) (USD Billion )
- 2.2 Global Psychiatric Digital Biomarkers Market : snapshot
- Chapter 3. Global Psychiatric Digital Biomarkers Market - Industry Analysis
- 3.1 Psychiatric Digital Biomarkers Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Shift toward preventive and personalized psychiatry boosts market growth
- 3.3 Market Restraints
- 3.3.1. Validation timelines and high development costs negatively impact market progress
- 3.4 Market Opportunities
- 3.4.1. Integration of biomarkers into DTx (Digital Therapeutics) will spur market growth
- 3.5 Market Challenges
- 3.5.1. Lack of interoperability and fragmentation of platforms restrict the growth of market
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Type
- 3.7.2 Market attractiveness analysis By Clinical Practice
- 3.7.3 Market attractiveness analysis By End-Use
- Chapter 4. Global Psychiatric Digital Biomarkers Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Psychiatric Digital Biomarkers Market: company market share, 2024
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Psychiatric Digital Biomarkers Market - Type Analysis
- 5.1 Global Psychiatric Digital Biomarkers Market overview: By Type
- 5.1.1 Global Psychiatric Digital Biomarkers Market share, By Type, 2024 and 2034
- 5.2 Wearables
- 5.2.1 Global Psychiatric Digital Biomarkers Market by Wearables, 2025 - 2034 (USD Billion )
- 5.3 Mobile-based Applications
- 5.3.1 Global Psychiatric Digital Biomarkers Market by Mobile-based Applications, 2025 - 2034 (USD Billion )
- 5.4 Sensors
- 5.4.1 Global Psychiatric Digital Biomarkers Market by Sensors, 2025 - 2034 (USD Billion )
- 5.5 Others
- 5.5.1 Global Psychiatric Digital Biomarkers Market by Others, 2025 - 2034 (USD Billion )
- 5.1 Global Psychiatric Digital Biomarkers Market overview: By Type
- Chapter 6. Global Psychiatric Digital Biomarkers Market - Clinical Practice Analysis
- 6.1 Global Psychiatric Digital Biomarkers Market overview: By Clinical Practice
- 6.1.1 Global Psychiatric Digital Biomarkers Market share, By Clinical Practice, 2024 and 2034
- 6.2 Diagnostic
- 6.2.1 Global Psychiatric Digital Biomarkers Market by Diagnostic, 2025 - 2034 (USD Billion )
- 6.3 Monitoring
- 6.3.1 Global Psychiatric Digital Biomarkers Market by Monitoring, 2025 - 2034 (USD Billion )
- 6.4 Predictive and Prognostic
- 6.4.1 Global Psychiatric Digital Biomarkers Market by Predictive and Prognostic, 2025 - 2034 (USD Billion )
- 6.5 Others
- 6.5.1 Global Psychiatric Digital Biomarkers Market by Others, 2025 - 2034 (USD Billion )
- 6.1 Global Psychiatric Digital Biomarkers Market overview: By Clinical Practice
- Chapter 7. Global Psychiatric Digital Biomarkers Market - End-Use Analysis
- 7.1 Global Psychiatric Digital Biomarkers Market overview: By End-Use
- 7.1.1 Global Psychiatric Digital Biomarkers Market share, By End-Use, 2024 and 2034
- 7.2 Healthcare Companies
- 7.2.1 Global Psychiatric Digital Biomarkers Market by Healthcare Companies, 2025 - 2034 (USD Billion )
- 7.3 Healthcare Providers
- 7.3.1 Global Psychiatric Digital Biomarkers Market by Healthcare Providers, 2025 - 2034 (USD Billion )
- 7.4 Payers
- 7.4.1 Global Psychiatric Digital Biomarkers Market by Payers, 2025 - 2034 (USD Billion )
- 7.5 Others
- 7.5.1 Global Psychiatric Digital Biomarkers Market by Others, 2025 - 2034 (USD Billion )
- 7.1 Global Psychiatric Digital Biomarkers Market overview: By End-Use
- Chapter 8. Psychiatric Digital Biomarkers Market - Regional Analysis
- 8.1 Global Psychiatric Digital Biomarkers Market Regional Overview
- 8.2 Global Psychiatric Digital Biomarkers Market Share, by Region, 2024 & 2034 (USD Billion )
- 8.3. North America
- 8.3.1 North America Psychiatric Digital Biomarkers Market, 2025 - 2034 (USD Billion )
- 8.3.1.1 North America Psychiatric Digital Biomarkers Market, by Country, 2025 - 2034 (USD Billion )
- 8.3.1 North America Psychiatric Digital Biomarkers Market, 2025 - 2034 (USD Billion )
- 8.4 North America Psychiatric Digital Biomarkers Market, by Type, 2025 - 2034
- 8.4.1 North America Psychiatric Digital Biomarkers Market, by Type, 2025 - 2034 (USD Billion )
- 8.5 North America Psychiatric Digital Biomarkers Market, by Clinical Practice, 2025 - 2034
- 8.5.1 North America Psychiatric Digital Biomarkers Market, by Clinical Practice, 2025 - 2034 (USD Billion )
- 8.6 North America Psychiatric Digital Biomarkers Market, by End-Use, 2025 - 2034
- 8.6.1 North America Psychiatric Digital Biomarkers Market, by End-Use, 2025 - 2034 (USD Billion )
- 8.4. Europe
- 8.4.2 Europe Psychiatric Digital Biomarkers Market, 2025 - 2034 (USD Billion )
- 8.4.2.1 Europe Psychiatric Digital Biomarkers Market, by Country, 2025 - 2034 (USD Billion )
- 8.4.2 Europe Psychiatric Digital Biomarkers Market, 2025 - 2034 (USD Billion )
- 8.4 Europe Psychiatric Digital Biomarkers Market, by Type, 2025 - 2034
- 8.4.1 Europe Psychiatric Digital Biomarkers Market, by Type, 2025 - 2034 (USD Billion )
- 8.5 Europe Psychiatric Digital Biomarkers Market, by Clinical Practice, 2025 - 2034
- 8.5.1 Europe Psychiatric Digital Biomarkers Market, by Clinical Practice, 2025 - 2034 (USD Billion )
- 8.6 Europe Psychiatric Digital Biomarkers Market, by End-Use, 2025 - 2034
- 8.6.1 Europe Psychiatric Digital Biomarkers Market, by End-Use, 2025 - 2034 (USD Billion )
- 8.5. Asia Pacific
- 8.5.3 Asia Pacific Psychiatric Digital Biomarkers Market, 2025 - 2034 (USD Billion )
- 8.5.3.1 Asia Pacific Psychiatric Digital Biomarkers Market, by Country, 2025 - 2034 (USD Billion )
- 8.5.3 Asia Pacific Psychiatric Digital Biomarkers Market, 2025 - 2034 (USD Billion )
- 8.4 Asia Pacific Psychiatric Digital Biomarkers Market, by Type, 2025 - 2034
- 8.4.1 Asia Pacific Psychiatric Digital Biomarkers Market, by Type, 2025 - 2034 (USD Billion )
- 8.5 Asia Pacific Psychiatric Digital Biomarkers Market, by Clinical Practice, 2025 - 2034
- 8.5.1 Asia Pacific Psychiatric Digital Biomarkers Market, by Clinical Practice, 2025 - 2034 (USD Billion )
- 8.6 Asia Pacific Psychiatric Digital Biomarkers Market, by End-Use, 2025 - 2034
- 8.6.1 Asia Pacific Psychiatric Digital Biomarkers Market, by End-Use, 2025 - 2034 (USD Billion )
- 8.6. Latin America
- 8.6.4 Latin America Psychiatric Digital Biomarkers Market, 2025 - 2034 (USD Billion )
- 8.6.4.1 Latin America Psychiatric Digital Biomarkers Market, by Country, 2025 - 2034 (USD Billion )
- 8.6.4 Latin America Psychiatric Digital Biomarkers Market, 2025 - 2034 (USD Billion )
- 8.4 Latin America Psychiatric Digital Biomarkers Market, by Type, 2025 - 2034
- 8.4.1 Latin America Psychiatric Digital Biomarkers Market, by Type, 2025 - 2034 (USD Billion )
- 8.5 Latin America Psychiatric Digital Biomarkers Market, by Clinical Practice, 2025 - 2034
- 8.5.1 Latin America Psychiatric Digital Biomarkers Market, by Clinical Practice, 2025 - 2034 (USD Billion )
- 8.6 Latin America Psychiatric Digital Biomarkers Market, by End-Use, 2025 - 2034
- 8.6.1 Latin America Psychiatric Digital Biomarkers Market, by End-Use, 2025 - 2034 (USD Billion )
- 8.7. The Middle-East and Africa
- 8.7.5 The Middle-East and Africa Psychiatric Digital Biomarkers Market, 2025 - 2034 (USD Billion )
- 8.7.5.1 The Middle-East and Africa Psychiatric Digital Biomarkers Market, by Country, 2025 - 2034 (USD Billion )
- 8.7.5 The Middle-East and Africa Psychiatric Digital Biomarkers Market, 2025 - 2034 (USD Billion )
- 8.4 The Middle-East and Africa Psychiatric Digital Biomarkers Market, by Type, 2025 - 2034
- 8.4.1 The Middle-East and Africa Psychiatric Digital Biomarkers Market, by Type, 2025 - 2034 (USD Billion )
- 8.5 The Middle-East and Africa Psychiatric Digital Biomarkers Market, by Clinical Practice, 2025 - 2034
- 8.5.1 The Middle-East and Africa Psychiatric Digital Biomarkers Market, by Clinical Practice, 2025 - 2034 (USD Billion )
- 8.6 The Middle-East and Africa Psychiatric Digital Biomarkers Market, by End-Use, 2025 - 2034
- 8.6.1 The Middle-East and Africa Psychiatric Digital Biomarkers Market, by End-Use, 2025 - 2034 (USD Billion )
- Chapter 9. Company Profiles
- 9.1 Mindstrong Health
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Akili Interactive
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Pear Therapeutics
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Cognoa
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Koa Health
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Quartet Health
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Headspace Health
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Spring Health
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Ginger
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Behavioral Signals
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Joon Health
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Empatica
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Otsuka Digital Health
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Neurotrack Technologies
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 NeuroFlow
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 and others.
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.1 Mindstrong Health
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Psychiatric Digital Biomarkers Market, 2025 - 2034 (USD Billion )
- 4. Porter’s Five Forces Analysis
- 5. Global Psychiatric Digital Biomarkers Market attractiveness, By Type
- 6. Global Psychiatric Digital Biomarkers Market attractiveness, By Clinical Practice
- 7. Global Psychiatric Digital Biomarkers Market attractiveness, By End-Use
- 8. Global Psychiatric Digital Biomarkers Market share by Type, 2025 and 2034 (USD Billion )
- 9. Global Psychiatric Digital Biomarkers Market by Wearables, 2025 - 2034 (USD Billion )
- 10. Global Psychiatric Digital Biomarkers Market by Mobile-based Applications, 2025 - 2034 (USD Billion )
- 11. Global Psychiatric Digital Biomarkers Market by Sensors, 2025 - 2034 (USD Billion )
- 12. Global Psychiatric Digital Biomarkers Market by Others, 2025 - 2034 (USD Billion )
- 13. Global Psychiatric Digital Biomarkers Market share by Clinical Practice, 2025 and 2034 (USD Billion )
- 14. Global Psychiatric Digital Biomarkers Market by Diagnostic, 2025 - 2034 (USD Billion )
- 15. Global Psychiatric Digital Biomarkers Market by Monitoring, 2025 - 2034 (USD Billion )
- 16. Global Psychiatric Digital Biomarkers Market by Predictive and Prognostic, 2025 - 2034 (USD Billion )
- 17. Global Psychiatric Digital Biomarkers Market by Others, 2025 - 2034 (USD Billion )
- 18. Global Psychiatric Digital Biomarkers Market share by End-Use, 2025 and 2034 (USD Billion )
- 19. Global Psychiatric Digital Biomarkers Market by Healthcare Companies, 2025 - 2034 (USD Billion )
- 20. Global Psychiatric Digital Biomarkers Market by Healthcare Providers, 2025 - 2034 (USD Billion )
- 21. Global Psychiatric Digital Biomarkers Market by Payers, 2025 - 2034 (USD Billion )
- 22. Global Psychiatric Digital Biomarkers Market by Others, 2025 - 2034 (USD Billion )
- 23. Global Psychiatric Digital Biomarkers Market share, by Region, 2025 and 2034
- 24. North America Psychiatric Digital Biomarkers Market, 2025 - 2034 (USD Billion )
- 25. Europe Psychiatric Digital Biomarkers Market, 2025 - 2034 (USD Billion )
- 26. Asia Pacific Psychiatric Digital Biomarkers Market, 2025 - 2034 (USD Billion )
- 27. Latin America Psychiatric Digital Biomarkers Market, 2025 - 2034 (USD Billion )
- 28. The Middle-East and Africa Psychiatric Digital Biomarkers Market, 2025 - 2034 (USD Billion )
Table Of Tables
- 1. Global Psychiatric Digital Biomarkers Market: Snapshot
- 2. Drivers of the Psychiatric Digital Biomarkers Market: impact analysis
- 3. North America Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 4. North America Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 5. North America Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 6. U.S. Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 7. U.S. Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 8. U.S. Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 9. Canada Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 10. Canada Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 11. Canada Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 12. Europe Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 13. Europe Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 14. Europe Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 15. Germany Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 16. Germany Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 17. Germany Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 18. France Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 19. France Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 20. France Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 21. U.K. Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 22. U.K. Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 23. U.K. Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 24. Italy Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 25. Italy Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 26. Italy Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 27. Spain Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 28. Spain Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 29. Spain Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 30. Rest of Europe Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 31. Rest of Europe Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 32. Rest of Europe Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 33. Asia Pacific Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 34. Asia Pacific Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 35. Asia Pacific Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 36. China Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 37. China Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 38. China Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 39. Japan Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 40. Japan Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 41. Japan Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 42. India Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 43. India Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 44. India Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 45. South Korea Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 46. South Korea Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 47. South Korea Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 48. South-East Asia Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 49. South-East Asia Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 50. South-East Asia Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 51. Rest of Asia Pacific Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 52. Rest of Asia Pacific Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 53. Rest of Asia Pacific Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 54. Latin America Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 55. Latin America Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 56. Latin America Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 57. Brazil Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 58. Brazil Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 59. Brazil Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 60. Mexico Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 61. Mexico Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 62. Mexico Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 63. Rest of Latin America Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 64. Rest of Latin America Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 65. Rest of Latin America Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 66. The Middle-East and Africa Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 67. The Middle-East and Africa Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 68. The Middle-East and Africa Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 69. GCC Countries Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 70. GCC Countries Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 71. GCC Countries Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 72. South Africa Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 73. South Africa Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 74. South Africa Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
- 75. Rest of Middle-East Africa Psychiatric Digital Biomarkers Market revenue, By Type, 2025 - 2034 (USD Billion )
- 76. Rest of Middle-East Africa Psychiatric Digital Biomarkers Market revenue, By Clinical Practice, 2025 - 2034 (USD Billion )
- 77. Rest of Middle-East Africa Psychiatric Digital Biomarkers Market revenue, By End-Use, 2025 - 2034 (USD Billion )
Methodology
FrequentlyAsked Questions
Psychiatric digital biomarkers are quantifiable and objective data collected through digital tools, such as wearable devices, applications, and smartphones, that help monitor, detect, and predict mental health conditions. These biomarkers study physiological, behavioral, and cognitive patterns, such as social interaction, movement, speech, and sleep, to support the treatment and diagnosis of various disorders.
The global psychiatric digital biomarkers market is projected to grow due to improvements in digital phenotyping, increased support from pharmaceutical companies, rising awareness, and a decrease in stigma.
According to study, the global psychiatric digital biomarkers market size was worth around USD 6.40 billion in 2024 and is predicted to grow to around USD 26.60 billion by 2034.
The CAGR value of the psychiatric digital biomarkers market is expected to be approximately 19.50% from 2025 to 2034.
North America is expected to lead the global psychiatric digital biomarkers market during the forecast period.
The key players profiled in the global psychiatric digital biomarkers market include Mindstrong Health, Akili Interactive, Pear Therapeutics, Cognoa, Koa Health, Quartet Health, Headspace Health, Spring Health, Ginger, Behavioral Signals, Joon Health, Empatica, Otsuka Digital Health, Neurotrack Technologies, and NeuroFlow.
The report examines key aspects of the psychiatric digital biomarkers market, including a detailed discussion of existing growth factors and restraints, as well as future growth opportunities and challenges that impact the market.
Choose License Type
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed